HOME >> BIOLOGY >> NEWS
Researchers identify genetic mutation that may alter tumor cell proliferation

beginning to change drug development efforts. This discovery adds to the short but growing list of molecular features that may help guide both current and future cancer drug development, said John Carpten, PhD, Senior Investigator and Director of TGens Integrated Cancer Genomics Division and the studys lead author. The next step is to determine the prevalence of the AKT1 mutation in different populations and, hopefully, use the information gained to stratify patients going into clinical trials for AKT inhibitors.

If validated by further studies, the identification of this recurring mutation has the potential to impact cancer treatment and drug development.

This is a gorgeous study that used a variety of sophisticated techniques to provide new insights into the tumorigenic process, said Bert Vogelstein, MD, Director of the Ludwig Center for Cancer Genetics & Therapeutics at The Johns Hopkins Kimmel Cancer Center.

James E. Thomas, PhD, of Lillys Cancer Discovery Research division, explained, AKT1 is a protein kinase or enzyme that plays a key role in activating survival, proliferation and metabolic pathways. Interestingly, other cellular proteins that regulate this network have also been shown to be mutated in a variety of cancers including lung, breast ovary, prostate, colorectal and brain cancers. This mutation in AKT1 is striking direct evidence for the role of AKT1 in cancer formation.

The identification of the AKT1 mutation was a collaborative effort between Eli Lilly & Company and TGen. This discovery demonstrates the importance of studying the genetic make up of cancers at the clinical level rather than relying on model systems, adds Jeffrey Trent, PhD, Scientific Director of TGen.

This is a key study highlighting Lillys commitment to translational research approaches in cancer drug discovery and development. Furthermore, this work is a great example of a successful public-private partnership at a global lev
'"/>

Contact: Amy Erickson
aerickson@tgen.org
602-343-8522
The Translational Genomics Research Institute
4-Jul-2007


Page: 1 2 3

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers discover method for identifying how cancer evades the immune system
9. Researchers use adult stem cells to create soft tissue
10. Researchers find gene that spurs development of the epididymis
11. Researchers isolate new risk marker for overweight children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... June 04, 2019 , ... ... for salient features of seizure risk signals, usually based on variations of amplitude, ... remains the only acceptable diagnostic methodology due to the complexity and variability of ...
(Date:5/31/2019)... ... May 29, 2019 , ... FileWave, ... and mobile, announces the launch of version 13.1. The new version extends FileWave’s ... API, and supports Apple’s spring release functionality. Version 13.1 builds on FileWave’s version ...
(Date:5/31/2019)... ... May 31, 2019 , ... ... Westchase in Houston, TX, announced today that Ben Reiter, Senior Writer at Sports ... of Wednesday, October 3rd.     , Reiter predicted the Houston Astros would win the ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... ... to demonstrate an efficient delivery system for the sustained release of human placental ... plasma-based gel system was able to deliver CM into the injured kidney, where ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce the go-live ... LDA’s ability to communicate directly with the marketplace; serving as a destination to ...
(Date:5/4/2019)... ... May 03, 2019 , ... ... the Diopsys® ffERG/Photopic Negative Response vision test, a new full field ... it is estimated that 6.3 million Americans will have glaucoma, with black Americans ...
(Date:5/2/2019)... ... May 02, 2019 , ... Boston ... greater Boston area. Gone are the days of painful hair transplant procedures. Boston ... Restoration System is the only robotic intelligent solution to offer a minimally invasive ...
Breaking Biology Technology:
Cached News: